Neurotune

Companies Neurotune

News Neurotune

• Neurotune Strengthens Management

  Neurotune AG announced personnel changes in its board of directors as well as management. Dr. Raimund Eckel will form the Board of Directors together Mr. Gerhard Musshafen and Dr. Bruno Oesch (Chairman). Furthermore, Dr. Armin W. Mäder, former CFO of Neurotune assumes the CEO position of Neurotune f more

• New members for Neurotune's Board of Directors

  The shareholders of Neurotune AG have elected Dr. Anders Härfstrand and Heinrich Rotach as new members of the board of directors at their annual general assembly on April 21, 2010. Anders Härfstrand is a medical doctor with extensive experience in neuropharmacology and an excellent track record as e more

• Neurotune announces regulatory approval for Phase II Clinical Trial to treat neuropathic pain in HIV patients

  Neurotune AG has received MCC ’s (the South African National Regulatory Agency) approval for a Phase II clinical study of neurotune’s lead compound NT-11624 for neuropathic pain caused by treatment with anti-retroviral medication. Neurotune’s Phase II trial (8-week, randomized, double-blind, placeb more

Market studies Neurotune

• IVF Hartmann Holding AG (VBSN) - Financial and Strategic SWOT Analysis Review

  IVF Hartmann Holding AG (IVF) is a Switzerland-based company. It is engaged in the development, production, and marketing of medical, pharmaceutical and hygiene products. The product portfolio of the company consists of rheumatism plasters, dressings, bandages, baby products, cotton wool, feminine h more

Websites Neurotune